Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Metronidazole & Clostridioides difficile infection (CDI) (initial), there is no distinct FDA or EMA approval specifically for “initial CDI” with metronidazole, though it is mechanistically and historically used in CDI and is approved for anaerobic infections including Clostridium spp.
Current treatment guidelines often recommend metronidazole for mild cases of CDI, especially when other first-line treatments are not available or appropriate. However, its role has declined over time due to resistance concerns and the availability of more effective therapies. Treatment choice should consider the severity of the infection, patient-specific factors, and local resistance patterns.
Ma…